Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT03424174 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Clinical Outcome and Cytokine Expression After TKA

Study acronym: TKA
StatusActive, Not Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. Re-verified, no change to tracked fieldsv7
  2. Study completion date: Dec 31, 2023 to Dec 31, 2028v6
  3. 2 versions Re-verified since Jul 21, 2020, no change to tracked fieldsv4-v5
  4. Primary completion date: Dec 2018 to Dec 31, 2023
    • Trial status: Recruiting to Active, Not Recruiting
    • Study completion date: Dec 2023 to Dec 31, 2023
    • Site details revised
    v3
  5. Secondary endpoints: details revised at 4 of 4 entriesv2
  6. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Comparison of coated and uncoated TKA with regard to cytokine expression and clinical results
Trial Details
NCT Number NCT03424174
Lead Sponsor Technische Universität Dresden
Conditions
(from sponsor)		 Osteoarthritis
Related terms Osteoarthritis
Enrollment 80 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov